Slate Stone Wealth, LLC Amgen Inc Transaction History

Slate Stone Wealth, LLC

$923 Million
Q2 2024

A detailed history of Slate Stone Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Slate Stone Wealth, LLC holds 23,046 shares of AMGN stock, worth $7.32 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

23,046

Previous 31,865 27.68%

Holding current value

$7.32 Million

Previous $9.06 Million 20.52%

% of portfolio

0.78%

Previous 0.91%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$262.75 - $319.31 $2.32 Million - $2.82 Million	-8,819 Reduced 27.68%	23,046 $7.2 Million
Q1 2024 Apr 26, 2024	BUY	$268.87 - $324.56 $3.92 Million - $4.74 Million	14,592 Added 84.48%	31,865 $9.06 Million
Q4 2023 Feb 01, 2024	BUY	$255.7 - $288.46 $799,062 - $901,437	3,125 Added 22.09%	17,273 $4.98 Million
Q3 2023 Oct 12, 2023	BUY	$218.65 - $271.46 $2.29 Million - $2.85 Million	10,486 Added 286.35%	14,148 $3.8 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $850,437 - $1.01 Million	-3,969 Reduced 52.01%	3,662 $813,000
Q1 2023 Aug 08, 2023	BUY	$225.79 - $275.2 $784,620 - $956,320	3,475 Added 94.89%	7,137 $1.73 Million
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $105,124 - $133,573	459 Added 6.4%	7,631 $2 Million
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $135,573 - $152,902	604 Added 9.2%	7,172 $1.62 Million
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $17,072 - $18,998	-74 Reduced 1.11%	6,568 $1.6 Million
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $833,445 - $922,008	3,801 Added 133.79%	6,642 $1.61 Million
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $10,540 - $12,062	-53 Reduced 1.83%	2,841 $639,000
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $62,831 - $73,615	-296 Reduced 9.28%	2,894 $615,000
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $55,477 - $64,650	-250 Reduced 7.27%	3,190 $794,000
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $92,610 - $110,282	428 Added 14.21%	3,440 $791,000
Q3 2020 Oct 27, 2020	BUY	$234.65 - $260.95 $68,517 - $76,197	292 Added 10.74%	3,012 $766,000
Q2 2020 Jul 29, 2020	BUY	$197.81 - $242.74 $989 - $1,213	5 Added 0.18%	2,720 $641,000
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $546 - $725	3 Added 0.11%	2,715 $551,000
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $118,067 - $151,756	624 Added 29.89%	2,712 $654,000
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $2,333 - $2,735	-14 Reduced 0.67%	2,088 $385,000
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $380,188 - $428,555	2,102 New	2,102 $399,000

Others Institutions Holding AMGN

# of Institutions

3,056

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Slate Stone Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Slate Stone Wealth, LLC with notifications on news.

Account

Slate Stone Wealth, LLC Amgen Inc Transaction History